Drug intelligence / Profile preview

carbon-14 glucose

Development stage
Unknown
Lead developer
Sigma Aldrich
Modality
Small Molecules, Antibody-Radionuclide Conjugates → Antibody Conjugates → Antibody-Based Therapeutics
Administration
Oral, Intravenous
01

Overview

Carbon-14 glucose is a radiolabeled analog of glucose where one or more carbon atoms are replaced by the radioactive isotope Carbon-14. It is primarily utilized as a metabolic tracer in biochemical research and clinical diagnostics. By incorporating the radioactive tracer, researchers can monitor the metabolic flux of glucose through pathways such as glycolysis, the pentose phosphate pathway, and the citric acid cycle. In oncology research, it is frequently used to study the metabolic reprogramming of cancer cells, including de novo lipid biosynthesis and energy metabolism under varying oxygen conditions (normoxia vs. anoxia). Clinically, C14-glucose has been historically used in diagnostic breath tests to detect small intestinal bacterial overgrowth (SIBO) or carbohydrate malabsorption by measuring the expiration of 14CO2. However, in many clinical applications, it has been superseded by stable isotope tracers like Carbon-13 to avoid radiation exposure.

Other names
uniformly labeled C14-glucose[14C]-D-glucosecarbon-14 labeled glucosecarbon14 labeled glucosecarbon 14 labeled glucose
02

Targets

GLUT1 (Glucose transporter 1)GCK (Glucokinase)

Beyond the preview

Go deeper on carbon-14 glucose.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on carbon-14 glucose.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call